Trace elements and oxidative stress in chronic obstructive pulmonary disease

Saudi Medical Journal

Volumn 26, Issue 12, 2005, Pages 1882-1885

  Isik, Birgul ^a   Isik, Rana S ^a   Ceylan, Ali ^a   Calik, Orhan ^a  

^a DICLE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLDIALKYLPHOSPHATASE; COPPER; MALONALDEHYDE; TRACE ELEMENT; ZINC;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; COPPER BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; HOSPITALIZATION; HUMAN; MALE; OXIDATIVE STRESS; PROTEIN LOCALIZATION; STATISTICAL SIGNIFICANCE; TISSUE DISTRIBUTION; ZINC BLOOD LEVEL;

AGED; ARYLDIALKYLPHOSPHATASE; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COPPER; FEMALE; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; PROBABILITY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SMOKING; STATISTICS, NONPARAMETRIC; TRACE ELEMENTS; ZINC;

EID: 31844457156     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. MacNee W. Oxidants/antioxidants and COPD. Chest 2000; 117: 303S-317S.
2. Rahman I, Swarska E, Henry M, Stolk J, MacNee W. Is there any relationship between plasma antioxidant capacity and lung function in smokers and in patients with chronic obstructive pulmonary disease? Thorax 2000; 55: 189-193.
3. World Health Organization. Risk factors in Global initiative for Chronic Obstructive Lung Disease, Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. NHLB/WHO Report. Geneva: WHO; 2003. p. 21-44.
4. Lannan S, Donaldson K, Brown D, MacNee W. Effects of cigarette smoke and its condensate on alveolar cell injury in vitro. Am J Physiol 1994; 266: L92-L100.
5. Çalikoglu M, Unlu A, Tamer L, Ercan B, Bugdayci R, Atik U. The levels of serum vitamin C, malondialdehyde and erythrocyte reduced glutathione in chronic pulmonary disease and in healthy smokers. Clin Chem Lab Med 2002; 40: 1028-1031.
6. Karadag F, Cildag O, Altinisik M, Kozaci L, Kiter G, Altun C. Trace elements as a component of oxidative stress in COPD. Respirology 2004; 9: 33-37.
7. Mango GW, Johnston CJ, Reynolds SD, Finkelstein JN, Plopper CG, Stripp BR. Clara cell secretory protein deficiency increases oxidant stress response in conducting airways. Am J Physiol 1998; 275: L348-L356.
8. Johnston CJ, Mango GW, Finkelstein JN, Stripp BR. Altered pulmonary response to hyperoxia in Clara cell secretory protein deficient mice. Am J Respir Cell Mol Biol 1997; 17: 147-155.
9. Rodrigo L, Hernandez AF, Lopez-Caballero JJ, Fernando G, Pla A. Immunohistochemical evidence for the expression and induction of paraoxonase in rat liver, kidney, lung and brain tissue implications for its physiological role. Chem Biol Interact 2001; 137: 123-137.
10. Schiavon R, Battaglia P, De Fanti E, Fasolin A, Biasioli S, Targa L, et al. HDL3-related decreased serum (PON1) activity in uremic patients: compression with the PON1 allele polymorphism. Clin Chim Acta 2002; 324: 39-44.
11. Petruzzelli S, Hietanen E, Bartsch H, Camus AM, Mussi A, Angeletti CA, et al. Pulmonary lipid peroxidation in cigarette smokers and lung cancer patients. Chest 1990; 98: 930-935.
12. Huang YL, Sheu JY, Lin TH. Association between oxidative stress and changes of trace elements in patients with breast cancer. Clin Biochem 1999; 32: 131-136.
13. Rahman I, Morrison D, Donaldson K, MacNee W. A systemic oxidative stress in asthma, COPD and smokers. Am J Respir Crit Care Med 1996; 154: 1055-1060.
14. Buege JA, Aust SD. Microsomal lipid peroxidation, Methods Enzymol 1978; 52: 301-310.
15. Eckerson HW, Romson J, Wyte C, La Du BN. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am J Hum Genet 1993; 35: 214-227
16. Chan PC, Peller OG, Kesner L. Copper(II)-catalyzed lipid peroxidation in liposomes and erythrocyte membranes. Lipids 1982; 17: 331-337.
17. Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human disease: An overview. Methods Enzymol 1990; 186: 81-85.
18. Molteni A, Ward WF, Kim YT, Shetty R, Brizio-Molteni L, Giura R, et al. Serum copper concentrations as an index of lung injury. Adv Exp Med Biol 1989; 258: 273-285.
19. Tadzhiev FS. Trace elements in the pathogenesis and treatment of chronic bronchitis (a clinico-experimental study). Ter Arkh 1991; 63: 68-70.
20. Ward WF, Molteni A, Ts'ao C, Ischiropoulos H. Serum copper concentration as an index of experimental lung injury. Adv Exp Med Biol 1989; 258: 287-302.
21. Colak O, Alatas O, Akyuz F, Kanbak G, Inal M. Antioxidant status in chronic obstructive pulmonary disease. Tr J Med S Sci 1995; 24: 305-307.
22. Boemi M, Sirolla C, Testa R, Cenerelli S, Fumelli P, James RW. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients. Diabet Med 2004; 21: 423-427.
23. James RW, Leviev I, Righetti A. Smoking is associated with reduced paraoxonase activity and concentration in patients with coronary artery disease. Circulation 2000; 101: 2252-2257.
24. Pryor WA, Stoen K. Oxidants in cigarette smoke: radicals, hydrogen peroxide, peroxy nitrate and peroxynitrate. Ann N Y Acad Sci 1993; 686: 12-27.